These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1115569)

  • 41. Patterns of heroin addiction in the District of Columbia.
    DuPont RL; Greene MH
    Proc Natl Conf Methadone Treat; 1973; 1():786-93. PubMed ID: 4808234
    [No Abstract]   [Full Text] [Related]  

  • 42. Recent developments in maintenance prescribing and monitoring in the United Kingdom.
    Brewer C
    Bull N Y Acad Med; 1995; 72(2):359-70. PubMed ID: 10101376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The oral absorption of methadone from a new parenterally nonabusable tablet.
    Van Harken DR; Monteleone P; Caruso FS; Bloom WA
    Proc Natl Conf Methadone Treat; 1973; 2():1355-61. PubMed ID: 4808288
    [No Abstract]   [Full Text] [Related]  

  • 44. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing patterns of multiple drug use among applicants to a multimodality drug treatment program.
    Gould LC; Kleber HD
    Arch Gen Psychiatry; 1974 Sep; 31(3):408-13. PubMed ID: 4412393
    [No Abstract]   [Full Text] [Related]  

  • 47. Harm-reduction strategies weapon of choice in BC's battle with drug addiction.
    Kent H
    CMAJ; 1996 Sep; 155(5):571-3. PubMed ID: 8804264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heroin addicts on methadone replacement: a study of dropouts.
    Adams RG; Capel WC; Bloom WA; Stewart GT
    Int J Addict; 1971 Jun; 6(2):269-77. PubMed ID: 5163941
    [No Abstract]   [Full Text] [Related]  

  • 49. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort.
    Vigna-Taglianti FD; Burroni P; Mathis F; Versino E; Beccaria F; Rotelli M; Garneri M; Picciolini A; Bargagli AM;
    Subst Use Misuse; 2016; 51(3):295-309. PubMed ID: 26872763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment.
    Maremmani I; Pacini M; Pani PP; Popovic D; Romano A; Maremmani AG; Deltito J; Perugi G
    J Addict Dis; 2009 Oct; 28(4):382-8. PubMed ID: 20155607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methadone disks. Injectable-noninjectable tablets.
    Jaffe JH; Fritz K; Kaistha KK
    Arch Gen Psychiatry; 1971 Dec; 25(6):525-6. PubMed ID: 5141372
    [No Abstract]   [Full Text] [Related]  

  • 54. Managing illicit drug use. A practical guide.
    Wodak A
    Drugs; 1994 Mar; 47(3):446-57. PubMed ID: 7514974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective.
    Bell J
    Addiction; 2010 Sep; 105(9):1531-7. PubMed ID: 20626373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial: Methadone maintenance.
    Lancet; 1975 Jan; 1(7900):208-9. PubMed ID: 47433
    [No Abstract]   [Full Text] [Related]  

  • 57. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating drug-crime relationships.
    Swezey RW
    Int J Addict; 1973; 8(4):701-21. PubMed ID: 4761649
    [No Abstract]   [Full Text] [Related]  

  • 59. Adolescents and short term, low dose methadone maintenance.
    DeAngelis GG; Lehmann WX
    Int J Addict; 1973; 8(5):853-63. PubMed ID: 4781422
    [No Abstract]   [Full Text] [Related]  

  • 60. Characteristics of clients "enrolled" in an unauthorized methadone treatment program.
    Goldberg EL; Nightingale SL
    Proc Natl Conf Methadone Treat; 1973; 1():752-9. PubMed ID: 4808229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.